Promise and challenges of traditional Chinese medicine,specifically Calculus bovis,in liver cancer treatment  

作　　者：Ao-Xi Xu Zhi-Feng Zhao Li Zhu Yi-Heng Zhang Yan Li Yu-Fan Wei Bo-Ya Zhang Bin Jiang Tian-Ze Gao Meng-Si Li Jia-Yu Liu 

机构地区：[1]School of Medicine,Nankai University,Tianjin 300071,China [2]Department of General Surgery,The First Medical Center of Chinese People's Liberation Army General Hospital,Beijing 100853,China [3]Medical School of Chinese People's Liberation Army,Medical School of Chinese People's Liberation Army,Beijing 100853,China [4]Department of Hepatobiliary and Pancreative Surgery,The First Medical Center,Chinese People's Liberation Army General Hospital,Beijing 100853,China [5]Department of Surgery,Mancheng District People's Hospital,Baoding 072150,Hebei Province,China [6]Department of Neurosurgery,First Medical Centre of Chinese People's Liberation Army General Hospital,Beijing 100853,China

出　　处：《World Journal of Gastroenterology》2024年第40期4380-4385,共6页世界胃肠病学杂志（英文）

摘　　要：Liver cancer,one of the most common malignancies worldwide,ranks sixth in incidence and third in mortality.Liver cancer treatment options are diverse,inclu-ding surgical resection,liver transplantation,percutaneous ablation,transarterial chemoembolization,radiotherapy,chemotherapy,targeted therapy,immuno-therapy,and traditional Chinese medicine(TCM).A multidisciplinary team(MDT)is essential to customize treatment plans based on tumor staging,liver function,and performance status(PS),ensuring individualized patient care.Treatment decisions require a MDT to tailor strategies based on tumor staging,liver function,and PS,ensuring personalized care.The approval of new first-line and second-line drugs and the establishment of standard treatments based on immune checkpoint inhibitors have significantly expanded treatment options for advanced liver cancer,improving overall prognosis.However,many patients do not respond effectively to these treatments and ultimately succumb to the disease.Modern oncology treatments,while extending patient survival,often come with severe side effects,resistance,and damage to the body,negatively impacting quality of life.Huang et al's study published at World Journal of Gastroenterology rigorously validates the anticancer properties of Calculus bovis,enhancing our understanding of TCM and contributing to new liver cancer treatment strategies.For over 5000 years,TCM has been used in East Asian countries like China to treat various diseases,including liver conditions.Analysis of real-world clinical data suggests that for patients with advanced-stage tumors lacking effective treatments,integrated TCM therapies could provide significant breakthroughs.

关 键 词：Traditional Chinese medicine Liver cancer Calculus bovis TREATMENT PROMISE CHALLENGES 

分 类 号：R735.7[医药卫生—肿瘤]